BRIEF-Hansoh Pharmaceutical Says Units Entered License Agreement With Unit Of Merck Sharp + Dohme LlcDec 18 (Reuters) - Hansoh Pharmaceutical Group Company Ltd 3692.HK:
UNITS ENTERED EXCLUSIVE GLOBAL LICENSE AGREEMENT WITH UNIT OF MERCK SHARP + DOHME LLC
LICENSORS TO RECEIVE UPFRONT PAYMENT OF US$112 MILLION AND ELIGIBLE TO RECEIVE UP TO US$1.9 BILLION IN MILESTONE PAYMENTS
Further company coverage: 3692.HK
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments